NAS:CTNM (USA)
Â
Class A Common Stock
$
16.31
+0.19 (+1.18%)
10:08 PM EST
Warning! GuruFocus detected
1 Severe warning sign
with CTNM.
Try a 7-Day Free Trial
to check it out.
New Key Statistics Module, Z-Score and F-Score
NAS:CTNM Key Ratios
| Market Cap $ M | 419.55 |
| Enterprise Value $ M | 302.23 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 5.79 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 50.00 |
| EPS (TTM) $ | -0.60 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -18.49 |
| EV-to-EBITDA | -18.60 |
| PEG | -- |
| Shares Outstanding M | 25.72 |
| Net Margin (%) | -- |
| Operating Margin % | -- |
| Pre-tax Margin (%) | -- |
| Quick Ratio | 19.20 |
| Current Ratio | 19.20 |
| ROA % (ttm) | -12.36 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -402.51 |
| Dividend Yield % | -- |
| Altman Z-Score | -- |
CTNM Number of Guru Trades
CTNM Volume of Guru Trades
Gurus Latest Trades with NAS:CTNM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CTNM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Contineum Therapeutics Inc Insider Transactions
No Available Data
News about NAS:CTNM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers